Abstract
In this study, we defined an in vitro inflammatory condition consisting of interleukin-beta and tissue necrosis factor-alpha and showed that naive MSCs in the inflammatory condition, could be turned into pro-inflammatory cells. We investigated pre-treatment conditions to improve MSCs’ anti-inflammatory properties and we found the use of cytokines including INF-gamma could enhance indoleamine 2,3-dioxygenase(IDO) activity and relieve pro-inflammatory changes when encountered the in vitro inflammatory condition. We believe that this result could contribute in the development of cell therapeutics using mesenchymal stem cells with enhanced anti-inflammatory properties.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
